Editorial – Page 16 – ExecEdge

Taiho Pharmaceutical to Buy Araris Biotech for Initial $400M

Taiho Pharmaceutical to Buy Araris Biotech for Initial $400M

By Daniella Parra Taiho Pharmaceutical said it will acquire Araris Biotech, a leader in antibody drug conjugates (ADCs), for an initial $400 million, with potential additional milestone payments of up to $740 million. Araris’ AraLinQ platform enhances ADC drug design,...

HF Foods Q4 Net Revenue Rises 8.7%, Adjusted EBITDA Up 39.4%

HF Foods Q4 Net Revenue Rises 8.7%, Adjusted EBITDA Up 39.4%

By Karen Roman HF Foods Group Inc. (Nasdaq: HFFG) said fourth quarter net revenue increased 8.7% to $305.3 million compared to $280.9 million in the year prior. Quarterly adjusted EBITDA rose 39.4% to $14.5 million in comparison to $10.4 million,...

Grove Delivers Positive Cash Flow; Acquires 8Greens, Grab Green

Grove Delivers Positive Cash Flow; Acquires 8Greens, Grab Green

By Karen Roman Grove Collaborative Holdings, Inc. (NYSE: GROV) said annual adjusted EBITDA was $1.3 million, increasing $10.5 million year-over-year. Operating cash flow for Q4 was $0.3 million, making it the third consecutive quarter with positive results, it said. Grove...

Input your search keywords and press Enter.